IGF1 and Alzheimer disease: In addition, altered neuronal IGF-1 function can contribute to the neuronal pathology and overall synaptic caused by APP- Aβ clearance in the apolipoprotein E (APOE) ε carriers, thus possibly leading to increased neuritic plaque formation in AD [50].